Revision of Scratching the Surface of Psychodermatology: Where Skin and Psychiatry Meet from Tue, 02/17/2026 - 13:33

Course Description

This session introduces psychodermatology, an under-recognized field that explores the bidirectional relationship between psychological factors and skin disease. Learners will examine the high prevalence of psychiatric comorbidities in dermatology and classification of psychodermatologic disorders. The webinar highlights current practice gaps, including limited clinician training, restricted access to specialty care, and a lack of robust evidence to guide treatment. Participants will learn how integrated care models unite dermatology, psychiatry, psychology, and psychiatric pharmacy, and support individualized pharmacologic and nonpharmacologic management. By the end of the session, learners will be equipped to apply psychodermatology principles in practice, improving holistic, collaborative, and empathetic care for patients with overlapping dermatologic and psychiatric needs.

Learning Objectives

  1. Describe the bidirectional relationship between skin and mental health.
  2. Assess psychotropic and dermatologic treatment–related adverse effects.
  3. Outline a comprehensive treatment plan for psychocutaneous disorders, including pharmacotherapy, psychotherapy, and holistic approaches.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Faculty

John Koo, MD
View biographical information

John Koo, MD

Professor, University of California San Francisco Medical Center

Course Requirements

To receive ACPE credit for this session, you must:

  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the evaluation at the end of the activity.
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Continuing Education Credit and Disclosures

Activity Dates: # - #
ACPE Contact Hours: #.##
ACPE Number: 0284-0000-##-###-###-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.